Samonigg H - Search Results

1

Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.

Schmid M, Samonigg H, Stöger H, Auer H, Sternthal MH, Wilders-Truschnig M, Reisinger EC. Schmid M, et al. Among authors: samonigg h. Clin Infect Dis. 1995 Jun;20(6):1543-6. doi: 10.1093/clinids/20.6.1543. Clin Infect Dis. 1995. PMID: 7548507

2

Gamma knife radiosurgery and albendazole for cerebral alveolar hydatid disease.

Schmid M, Pendl G, Samonigg H, Ranner G, Eustacchio S, Reisinger EC. Schmid M, et al. Among authors: samonigg h. Clin Infect Dis. 1998 Jun;26(6):1379-82. doi: 10.1086/516351. Clin Infect Dis. 1998. PMID: 9636867

3

Sequential treatment of recurrent mesenteric desmoid tumor.

Bauernhofer T, Stöger H, Schmid M, Smola M, Gürtl-Lackner B, Höfler G, Ranner G, Reisinger E, Samonigg H. Bauernhofer T, et al. Among authors: samonigg h. Cancer. 1996 Mar 15;77(6):1061-5. Cancer. 1996. PMID: 8635124 Review.

4

Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.

Samonigg H, Wilders-Truschnig M, Loibner H, Plot R, Rot A, Kuss I, Werner G, Stöger H, Wrann M, Herlyn D, et al. Samonigg H, et al. Clin Immunol Immunopathol. 1992 Dec;65(3):271-7. doi: 10.1016/0090-1229(92)90157-j. Clin Immunol Immunopathol. 1992. PMID: 1451329

5

A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.

Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Stöger H, et al. Among authors: samonigg h. Cancer Chemother Pharmacol. 1994;35(2):174-8. doi: 10.1007/BF00686643. Cancer Chemother Pharmacol. 1994. PMID: 7987997 Clinical Trial.

6

[Scurvy after a suicide attempt by starvation].

Stöger H, Wilders-Truschnig M, Schmid M, Petek W, Samonigg H. Stöger H, et al. Among authors: samonigg h. Dtsch Med Wochenschr. 1994 Apr 22;119(16):589-92. doi: 10.1055/s-2008-1058734. Dtsch Med Wochenschr. 1994. PMID: 8162842 German.

7

The presence of immunosuppressive 'p15E-like' factors in the serum and urine of patients suffering from malign and benign breast tumours.

Stöger H, Wilders-Truschnig M, Samonigg H, Schmid M, Bauernhofer T, Tiran A, Tas M, Drexhage HA. Stöger H, et al. Among authors: samonigg h. Clin Exp Immunol. 1993 Sep;93(3):437-41. doi: 10.1111/j.1365-2249.1993.tb08197.x. Clin Exp Immunol. 1993. PMID: 8370172 Free PMC article.

8

A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.

Samonigg H, Wilders-Truschnig M, Kuss I, Plot R, Stöger H, Schmid M, Bauernhofer T, Tiran A, Pieber T, Havelec L, Loibner H. Samonigg H, et al. J Immunother. 1999 Nov;22(6):481-8. J Immunother. 1999. PMID: 10570746 Clinical Trial.

9

Combined treatment of metastatic osteosarcoma of the spine.

Bauernhofer T, Stöger H, Kasparek AK, Ploner F, Kuss I, Pieber TR, Kotz R, Samonigg H. Bauernhofer T, et al. Among authors: samonigg h. Oncology. 1999 Nov;57(4):265-8. doi: 10.1159/000012058. Oncology. 1999. PMID: 10575309 Review.

10

Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.

Samonigg H, Stöger H, Kasparek AK, Schmid M, Dusleag J, Pfeiffer K, Smola M, Steindorfer P, Lechner P. Samonigg H, et al. Cancer Chemother Pharmacol. 1991;27(6):477-80. doi: 10.1007/BF00685163. Cancer Chemother Pharmacol. 1991. PMID: 2013118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters